Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?
- 1 December 2003
- journal article
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 186 (6), 665-669
- https://doi.org/10.1016/j.amjsurg.2003.08.023
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- Tumor volume as a prognostic factor for sarcomatosisCancer, 2002
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- Gastrointestinal stromal tumor workshopHuman Pathology, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene familyNature, 1986